In Response to: Dicpinigaitis AJ, Ogulnick JV, Mayer AS, Gandhi CD, Al-Mufti F. Increase in Ruptured Cerebral Arteriovenous Malformations and Mortality in the United States: Unintended Consequences of the ARUBA Trial

Affiliations

Alis Dicpinigaitis et al. Stroke Vasc Interv Neurol. 2023.

. 2023 Jan 3;3(1):e000700.

doi: 10.1161/SVIN.122.000700. eCollection 2023 Jan.

No abstract available

References

1. Kim AS, Guterman EL, Kim H. Reply to “Increase in Ruptured Cerebral Arteriovenous Malformations and Mortality in the United States: Unintended Consequences of the ARUBA Trial?” Stroke Vasc Interv Neurol. 2022.
1. Dicpinigaitis AJ, Ogulnick JV, Mayer AS, Gandhi CD, Al‐Mufti F. Increase in ruptured cerebral arteriovenous malformations and mortality in the United States: unintended consequences of the ARUBA Trial? Stroke Vasc Interv Neurol. 2023;3:e000442. 10.1161/SVIN.122.000442 - DOI
1. Berman MF, Stapf C, Sciacca RR, Young WL. Use of ICD‐9 coding for estimating the occurrence of cerebrovascular malformations. AJNR Am J Neuroradiol. 2002;23:700‐705. - PMC - PubMed
1. Goldstein LB. Accuracy of ICD‐9‐CM coding for the identification of patients with acute ischemic stroke. Stroke. 1998;29:1602‐1604. - PubMed
1. Luther E, McCarthy DJ, Burks J, Govindarajan V, Lu VM, Silva M, Lang M, Gross BA, Starke RM. National reduction in cerebral arteriovenous malformation treatment correlated with increased rupture incidence. J Neurointerv Surg. 2022:neurintsurg‐2022‐019110. - PMC - PubMed